Shiitake (Lentinula edodes) is één van de meest populaire eetbare paddenstoelen. Deze paddenstoel en zijn componenten genieten veel wetenschappelijke belangstelling en worden intensief bestudeerd vanwege de gezondheidseffecten. De interesse in de werking van de Shiitake paddenstoel gaat al meer dan 3000 jaar terug. In de Oriënt wordt shiitake sinds mensenheugenis gebruikt voor veel uiteenlopende aandoeningen.
Beste bezoeker, u heeft geen toegang.
Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.
U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!
Auteur
Trefwoorden:
Figuren
Verschenen in
Referenties
1. Hobbs, Ch. (2000). Medicinal value of Lentinus edodes: a literature review. Int. J. Med. Mush., 2, 287-302.
2. Suzuki, M, Takatsuki, F, Maeda, Y, Hamuro, J and Chihara, G (1994). Lentinan: Rationale for Development and Therapeutic Potential. Clinical Immunotherapy 2(2), 121-133.
3. Maeda, YY and Chihara, G (1999). Immunomodulatory Agents from Plants. In Lentinan and other antitumoral polysaccharides, ed H Wagner, (Birkhauser Verlag).
4. Ikekawa, T. (2001). Beneficial effects of edible medicinal mushrooms on health care. Int. J. Med. Mush. 3, 291-298.
5. Yoshino S, Watanabe S, Imano M, et al. Improvement of QOL and prognosis by treatment of superfine dispersed lentinan in patients with advanced gastric cancer. Hepatogastroenterology. 2010 Jan-Feb;57(97):172-7.
6. Yagi M, Watanabe S, Yoshino S, et al. [Provision for adverse effect of S-1 containing chemotherapy in patients with advanced digestive cancer--combination with superfine dispersed lentinan]. Gan To Kagaku Ryoho. 2010 Mar;37(3):457-62.
7. Hazama S, Watanabe S, Ohashi M, et al. Efficacy of orally administered superfine dispersed lentinan (beta-1,3-glucan) for the treatment of advanced colorectal cancer. Anticancer Res. 2009 Jul;29(7):2611-7.
8. Isoda N, Eguchi Y, Nukaya H, et al. Clinical efficacy of superfine dispersed lentinan (beta-1,3-glucan) in patiënten with hepatocellular carcinoma. Hepatogastroenterology. 2009 Mar-Apr;56(90):437-41.
9. Shimizu K, Watanabe S, Watanabe S, et al. Efficacy of oral administered superfine dispersed lentinan for advanced pancreatic cancer. Hepatogastroenterology. 2009 Jan-Feb;56(89):240-4.
10. Yamada J. [Alleviation of seasonal allergic symptoms with superfine beta-1,3-glucan: a randomized study]. Nippon Ganka Gakkai Zasshi. 2009 Nov;113(11):1082-7. Review. Japanese.
11. Yamada J, Hamuro J, Hatanaka H et al. Alleviation of seasonal allergic symptoms with superfine beta-1,3-glucan: a randomized study. J Allergy Clin Immunol. 2007 May;119(5):1119-26. Epub 2007 Mar 26.
12. Zhang L, Li X, Xu X, Zeng F. 2005Correlation between antitumor activity, molecular weight, and conformation of lentinan. Carbohydr Res. 2005 Jun 13;340(8):1515-21.
13. McCormack E, Skavland J, Mujic M, et al. Lentinan: hematopoietic, immunological, and efficacy studies in a syngeneic model of acute myeloid leukemia. Nutr Cancer. 2010;62(5):574-83.
14a. Koczywas M, Cristea MC, Reckamp KL, et al. Posterpresentation 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. December 9-11, 2010, Chicago, Illinois.
http://www.abstractsonline.com/plan/ViewAbstract.aspx?mID=2626&sKey=c8e5...
14b. Posterpresentatie 14e World Conference on Lung Cancer, 3-7 July 2011, Amsterdam RAI.
